Death of cortical and striatal neurons induced by mitochondrial defect involves differential molecular mechanisms

被引:46
作者
Galas, MC
Bizat, N
Cuvelier, L
Bantubungi, K
Brouillet, E
Schiffmann, SN
Blum, D
机构
[1] ULB Erasme, Neurophysiol Lab, B-1070 Brussels, Belgium
[2] CEA, Serv Hosp Frederic Joliot,DRM, CNRS, URACEA 2210, F-91406 Orsay, France
关键词
cell death; Huntington's disease; 3-nitropropionic acid; apoptosis; cortex; striatum;
D O I
10.1016/j.nbd.2003.09.013
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
An important aspect of Huntington's disease (HD) pathogenesis which may have important therapeutic implications is that the cellular events leading to cell death may be different in cortical and striatal neurons. In the present study, we characterized cellular changes in cortical and striatal neurons treated with the mitochondrial toxin 3-nitropropionic acid (3NP) in culture. Degeneration induced by 3NP was similar in both striatal and cortical neurons as observed using markers of cell viability and DNA fragmentation. However, in striatal neurons, 3NP produced a marked delocalization of Bad, Bax, cytochrome c and Smac while this was not observed in cortical neurons. Death of striatal neurons was preceded by activation of calpain and was blocked by calpain inhibitor I. In cortical neurons, calpain was not activated and calpain inhibitor I was without effect. In both cell types, caspase-9 and -3 were not activated by 3NP and the caspase inhibitor zVAD-fmk did not provide neuroprotective effect. Interestingly, treatment with staurosporine (STS) triggered caspase-9 and -3 in cortical and striatal cells, suggesting that the molecular machinery related to caspase-dependent apoptosis was functional in both cell types even though this machinery was not involved in 3NP toxicity. The present results clearly demonstrate that under mitochondrial inhibition, striatal and cortical neurons die through different pathways. This suggests that mitochondrial defects in HD may trigger the death of cortical and striatal neurons through different molecular events. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:152 / 159
页数:8
相关论文
共 50 条
[1]  
Ackrell B A, 1978, Methods Enzymol, V53, P466
[2]   Selective neurodegeneration in Huntington's disease [J].
Albin, RL .
ANNALS OF NEUROLOGY, 1995, 38 (06) :835-836
[3]   Energetics in the pathogenesis of neurodegenerative diseases [J].
Beal, MF .
TRENDS IN NEUROSCIENCES, 2000, 23 (07) :298-304
[4]  
BEAL MF, 1993, J NEUROSCI, V13, P4181
[5]  
Bizat N, 2003, J NEUROSCI, V23, P5020
[6]   In vivo calpain/caspase cross-talk during 3-nitropropionic acid-induced striatal degeneration -: Implication of a calpain-mediated cleavage of active caspase-3 [J].
Bizat, N ;
Hermel, JM ;
Humbert, S ;
Jacquard, C ;
Créminon, C ;
Escartin, C ;
Saudou, F ;
Krajewski, S ;
Hantraye, P ;
Brouillet, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (44) :43245-43253
[7]  
Blum D, 2003, J NEUROSCI, V23, P5361
[8]   Adenosine receptors and Huntington's disease: implications for pathogenesis and therapeutics [J].
Blum, D ;
Hourez, R ;
Galas, MC ;
Popoli, P ;
Schiffmann, SN .
LANCET NEUROLOGY, 2003, 2 (06) :366-374
[9]   Striatal and cortical neurochemical changes induced by chronic metabolic compromise in the 3-nitropropionic model of Huntington's disease [J].
Blum, D ;
Galas, MC ;
Gall, D ;
Cuvelier, L ;
Schiffmann, SN .
NEUROBIOLOGY OF DISEASE, 2002, 10 (03) :410-426
[10]  
Blum D, 2002, J NEUROSCI, V22, P9122